Y, J., T, C., Z, Y., S, B., J, E., P, B., . . . M, B. (2026). Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space. Journal of the American Heart Association, 15(12), e046837. https://doi.org/10.1161/JAHA.125.046837
Chicago Style (17th ed.) CitationY, Jelwan, Cao T, Yao Z, Burka S, Erhabor J, Berning P, Dzaye O, and Blaha M. "Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space." Journal of the American Heart Association 15, no. 12 (2026): e046837. https://doi.org/10.1161/JAHA.125.046837.
MLA (9th ed.) CitationY, Jelwan, et al. "Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space." Journal of the American Heart Association, vol. 15, no. 12, 2026, p. e046837, https://doi.org/10.1161/JAHA.125.046837.